364 related articles for article (PubMed ID: 35073964)
41. SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.
Wu L; Kou F; Ji Z; Li B; Zhang B; Guo Y; Yang L
Cell Death Dis; 2021 May; 12(5):439. PubMed ID: 33935284
[TBL] [Abstract][Full Text] [Related]
42. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.
Sasaki M; Kawahara K; Nishio M; Mimori K; Kogo R; Hamada K; Itoh B; Wang J; Komatsu Y; Yang YR; Hikasa H; Horie Y; Yamashita T; Kamijo T; Zhang Y; Zhu Y; Prives C; Nakano T; Mak TW; Sasaki T; Maehama T; Mori M; Suzuki A
Nat Med; 2011 Jul; 17(8):944-51. PubMed ID: 21804542
[TBL] [Abstract][Full Text] [Related]
43. MiRNA-144-5p down-modulates CDCA3 to regulate proliferation and apoptosis of lung adenocarcinoma cells.
Luo J; Xia L; Zhang L; Zhao K; Li C
Mutat Res; 2022; 825():111798. PubMed ID: 36087462
[TBL] [Abstract][Full Text] [Related]
44. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
45. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
47. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
Hu B; Zhu X; Lu J
Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
[TBL] [Abstract][Full Text] [Related]
48. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
[TBL] [Abstract][Full Text] [Related]
49. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
50. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
Dai MS; Sun XX; Lu H
Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
[TBL] [Abstract][Full Text] [Related]
51. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
[TBL] [Abstract][Full Text] [Related]
52. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
[TBL] [Abstract][Full Text] [Related]
53. Effects of the Nonstructural Protein-Nucleolar and Coiled-Body Phosphoprotein 1 Protein Interaction on rRNA Synthesis Through Telomeric Repeat-Binding Factor 2 Regulation Under Nucleolar Stress.
Zhang M; Zeng Y; Wang F; Feng H; Liu Q; Li F; Zhao S; Zhao J; Liu Z; Zheng F; Liu H
AIDS Res Hum Retroviruses; 2024 Jun; 40(6):408-416. PubMed ID: 38062753
[TBL] [Abstract][Full Text] [Related]
54. Growth inhibitory effects of large subunit ribosomal proteins in melanoma.
Kardos GR; Dai MS; Robertson GP
Pigment Cell Melanoma Res; 2014 Sep; 27(5):801-12. PubMed ID: 24807543
[TBL] [Abstract][Full Text] [Related]
55. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
[No Abstract] [Full Text] [Related]
56. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
57. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
Liu T; Yang C; Wang W; Liu C
Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
[TBL] [Abstract][Full Text] [Related]
58. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
[TBL] [Abstract][Full Text] [Related]
60. LncRNA-LINC01089 inhibits lung adenocarcinoma cell proliferation and promotes apoptosis via sponging miR-543.
Xu Y; Lin L; Lv D; Yan S; He S; Ge H
Tissue Cell; 2021 Oct; 72():101535. PubMed ID: 33892399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]